Physician profile
Evan J Tobin
NPI 1588636989
$1,147.01
in general payments reported to CMS, 2019-2025
15 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $111 · 2021: $64.05 · 2023: $397 · 2024: $165 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $769.53 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $300.61 | 2023-2025 | |
| Genzyme Corporation | $145.45 | 2019-2024 | |
| Stryker Corporation | $128.53 | 2019-2024 | Clarifix Cryotherapy Device |
| Inspire Medical Systems, INC. | $97.08 | 2024-2025 | Inspire |
| Optinose US, INC. | $92.14 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $90.38 | 2023-2025 | Dupixent |
| Glaxosmithkline, LLC. | $87.04 | 2024-2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $52.99 | 2024 | |
| Checkpoint Surgical, INC | $38.20 | 2020 | |
| Alk-Abello, INC | $36.55 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $18.40 | 2025 | Jornay Pm |
| Teva Pharmaceuticals USA, INC. | $17.66 | 2021 | |
| Smith+Nephew, INC. | $15.30 | 2020 | |
| Hikma Pharmaceuticals USA | $13.60 | 2024 | Ryaltris |
| Hologic Sales and Service, LLC | $13.08 | 2023 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Tobin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.